- Home
- NERV vs KXIN Comparison
NERV vs KXIN Comparison
Compare NERV & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- KXIN
- Stock Information
- Founded
- NERV 2007
- KXIN 2015
- Country
- NERV United States
- KXIN China
- Employees
- NERV N/A
- KXIN N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- NERV Health Care
- KXIN Consumer Discretionary
- Exchange
- NERV Nasdaq
- KXIN Nasdaq
- Market Cap
- NERV 10.3M
- KXIN 9.0M
- IPO Year
- NERV 2014
- KXIN N/A
- Fundamental
- Price
- NERV $1.78
- KXIN $0.97
- Analyst Decision
- NERV Hold
- KXIN
- Analyst Count
- NERV 1
- KXIN 0
- Target Price
- NERV $5.00
- KXIN N/A
- AVG Volume (30 Days)
- NERV 18.1K
- KXIN 109.1K
- Earning Date
- NERV 05-05-2025
- KXIN 01-01-0001
- Dividend Yield
- NERV N/A
- KXIN N/A
- EPS Growth
- NERV N/A
- KXIN N/A
- EPS
- NERV 0.19
- KXIN N/A
- Revenue
- NERV N/A
- KXIN N/A
- Revenue This Year
- NERV N/A
- KXIN N/A
- Revenue Next Year
- NERV N/A
- KXIN N/A
- P/E Ratio
- NERV $9.00
- KXIN N/A
- Revenue Growth
- NERV N/A
- KXIN N/A
- 52 Week Low
- NERV $1.15
- KXIN $0.64
- 52 Week High
- NERV $3.69
- KXIN $29.52
- Technical
- Relative Strength Index (RSI)
- NERV 59.64
- KXIN 47.23
- Support Level
- NERV $1.52
- KXIN $0.88
- Resistance Level
- NERV $1.81
- KXIN $1.20
- Average True Range (ATR)
- NERV 0.17
- KXIN 0.12
- MACD
- NERV 0.04
- KXIN 0.02
- Stochastic Oscillator
- NERV 95.45
- KXIN 58.33
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.